which of the following insulin secretagogues agent used in DM type 2 is Contraindicated in MEN or medullary thyroid carcinoma -
- GLP - 1 receptor agonist
- DPP- IV inhibitors
- sulfonylurea
- Rapaglinide
which of the following insulin secretagogues agent used in DM type 2 is Contraindicated in MEN or medullary thyroid carcinoma -